Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017		Sep. 30, 2016
Cash flows from operating activities:
Net income	$ 34,876		$ 61,314
Adjustments to reconcile net income to net cash (used in) operating activities:
Amortization of premium or discount on fixed maturity securities	108		247
Net realized loss (gain) on sale of investments	63		(19)
Unrealized (gain) on trading securities	(67)		(83)
Unrealized (gain) on derivative embedded conversion feature	(31,226)		(62,587)
Equity-based compensation	415		484
Changes in assets and liabilities:
Accrued investment income	78		(18)
Other assets	(257)		(270)
Cash equivalents held in trust	(4,628)		1,358
Restricted cash	(3,873)		(1,476)
Losses and loss adjustment reserves	(106)		(2,733)
Losses payable	(24)		(395)
Unearned premiums	(237)		(463)
Accrued ceding commission expense	35		(8)
Accrued interest on notes payable	(203)		(24)
Loss contract reserve	(5,645)		(2,362)
Other liabilities	(289)		(626)
Total adjustments	(45,856)		(68,975)
Net cash used in operating activities	(10,980)		(7,661)
Cash flows from investing activities:
Purchase of investments	(19,973)		(130,469)
Proceeds from sales and maturities of investments	86,278		146,920
Net cash provided by investing activities	66,305		16,451
Cash flows from financing activities:
Redeemable convertible series B preferred stock dividends	(13,500)		(13,500)
Notes payable – principal repayments	(18,774)		(2,185)
Net cash used in financing activities	(32,274)		(15,685)
Increase (decrease) in cash and cash equivalents	23,051		(6,895)
Cash and cash equivalents, beginning of period	2,491	[1]	9,924
Cash and cash equivalents, end of period	25,542		3,029
Supplementary disclosure of cash flow information:
Cash paid during the period, Interest	$ 1,991		$ 2,008

[1] Balances derived from audited financial statements as of December 31, 2016.